Ubs Group Ag Anebulo Pharmaceuticals, Inc. Transaction History
Ubs Group Ag
- $452 Billion
- Q3 2024
A detailed history of Ubs Group Ag transactions in Anebulo Pharmaceuticals, Inc. stock. As of the latest transaction made, Ubs Group Ag holds 763 shares of ANEB stock, worth $1,159. This represents 0.0% of its overall portfolio holdings.
Number of Shares
763Holding current value
$1,159% of portfolio
0.0%Shares
9 transactions
Others Institutions Holding ANEB
# of Institutions
14Shares Held
7.34MCall Options Held
0Put Options Held
0-
22 Nw, LP Seattle, WA5.37MShares$8.16 Million11.7% of portfolio
-
Lvw Advisors, LLC641KShares$974,3790.16% of portfolio
-
Nantahala Capital Management, LLC New Canaan, CT511KShares$776,8300.06% of portfolio
-
Morgan Stanley New York, NY399KShares$606,8120.0% of portfolio
-
Ikarian Capital, LLC Dallas, TX158KShares$239,9500.05% of portfolio
About Anebulo Pharmaceuticals, Inc.
- Ticker ANEB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 25,633,200
- Market Cap $39M
- Description
- Anebulo Pharmaceuticals, Inc., a clinical-stage biotechnology company, engages in developing and commercializing treatments for people suffering from acute cannabinoid intoxication and substance addiction. Its lead product candidate is ANEB-001, a small molecule cannabinoid receptor antagonist to treat cannabinoid intoxication and overdose. The ...